Yield10 Bioscience, Inc.
YTEN
$0.2489
-$0.0111-4.27%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 60.00K | 87.00K | 111.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 60.00K | 87.00K | 111.00K |
| Cost of Revenue | 2.20M | 2.00M | 2.16M | 1.89M | 2.08M |
| Gross Profit | -2.20M | -2.00M | -2.10M | -1.80M | -1.97M |
| SG&A Expenses | 1.50M | 1.67M | 1.70M | 1.40M | 1.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.70M | 3.67M | 3.86M | 3.29M | 3.60M |
| Operating Income | -3.70M | -3.67M | -3.80M | -3.20M | -3.49M |
| Income Before Tax | -3.73M | -3.68M | -3.78M | -3.17M | -3.48M |
| Income Tax Expenses | -- | -- | -- | 129.00K | 9.00K |
| Earnings from Continuing Operations | -3.73M | -3.68M | -3.78M | -3.30M | -3.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.73M | -3.68M | -3.78M | -3.30M | -3.49M |
| EBIT | -3.70M | -3.67M | -3.80M | -3.20M | -3.49M |
| EBITDA | -3.63M | -3.59M | -3.73M | -3.14M | -3.42M |
| EPS Basic | -0.41 | -0.64 | -0.76 | -0.67 | -0.71 |
| Normalized Basic EPS | -0.26 | -0.40 | -0.47 | -0.40 | -0.44 |
| EPS Diluted | -0.41 | -0.64 | -0.76 | -0.67 | -0.71 |
| Normalized Diluted EPS | -0.26 | -0.40 | -0.47 | -0.40 | -0.44 |
| Average Basic Shares Outstanding | 8.99M | 5.73M | 5.00M | 4.94M | 4.92M |
| Average Diluted Shares Outstanding | 8.99M | 5.73M | 5.00M | 4.94M | 4.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
